Central 5-HT Neurotransmission Modulates Weight Loss Following Gastric Bypass Surgery in Obese Individuals

Overview

Journal J Neurosci

Specialty Neurology

Date 2015 Apr 10

PMID 25855196

Citations 25

Authors

M E Haahr

D L Hansen

P M Fisher

C Svarer

D S Stenbaek

K Madsen

J Madsen

J J Holst

W F C Baare

L Hojgaard

T Almdal

G M Knudsen

Affiliations

Soon will be listed here.

Abstract

The cerebral serotonin (5-HT) system shows distinct differences in obesity compared with the lean state. Here, it was investigated whether serotonergic neurotransmission in obesity is a stable trait or changes in association with weight loss induced by Roux-in-Y gastric bypass (RYGB) surgery. In vivo cerebral 5-HT2A receptor and 5-HT transporter binding was determined by positron emission tomography in 21 obese [four men; body mass index (BMI), 40.1 ± 4.1 kg/m(2)] and 10 lean (three men; BMI, 24.6 ± 1.5 kg/m(2)) individuals. Fourteen obese individuals were re-examined after RYGB surgery. First, it was confirmed that obese individuals have higher cerebral 5-HT2A receptor binding than lean individuals. Importantly, we found that higher presurgical 5-HT2A receptor binding predicted greater weight loss after RYGB and that the change in 5-HT2A receptor and 5-HT transporter binding correlated with weight loss after RYGB. The changes in the 5-HT neurotransmission before and after RYGB are in accordance with a model wherein the cerebral extracellular 5-HT level modulates the regulation of body weight. Our findings support that the cerebral 5-HT system contributes both to establish the obese condition and to regulate the body weight in response to RYGB.

Citing Articles

5-Methoxy-2-aminoindane Reverses Diet-Induced Obesity and Improves Metabolic Parameters in Mice: A Potential New Class of Antiobesity Therapeutics.

Baraghithy S, Gammal A, Permyakova A, Hamad S, Kocvarova R, Calles Y ACS Pharmacol Transl Sci. 2024; 7(8):2527-2543.

PMID: 39144560 PMC: 11320730. DOI: 10.1021/acsptsci.4c00353.

Effects of psilocybin on body weight, body composition, and metabolites in male and female mice.

Shakir J, Pedicini M, Bullock B, Hoen P, Macias L, Freiman J Physiol Behav. 2024; 284:114627.

PMID: 38964565 PMC: 11323168. DOI: 10.1016/j.physbeh.2024.114627.

Portuguese observational cross-sectional clinical imaging study protocol to investigate central dopaminergic mechanisms of successful weight loss through bariatric surgery.

Pais M, Crisostomo J, Abrunhosa A, Castelo-Branco M BMJ Open. 2024; 14(4):e080702.

PMID: 38569700 PMC: 10989096. DOI: 10.1136/bmjopen-2023-080702.

Effects of bariatric surgery and dietary interventions for obesity on brain neurotransmitter systems and metabolism: A systematic review of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) studies.

Al-Alsheikh A, Alabdulkader S, Miras A, Goldstone A Obes Rev. 2023; 24(11):e13620.

PMID: 37699864 PMC: 10909448. DOI: 10.1111/obr.13620.

Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression-a NeuroPharm study.

Rasmussen A, Larsen S, Ozenne B, Kohler-Forsberg K, Stenbaek D, Jorgensen M Transl Psychiatry. 2023; 13(1):247.

PMID: 37414758 PMC: 10325956. DOI: 10.1038/s41398-023-02551-x.

References

Meyer J, Kapur S, Eisfeld B, Brown G, Houle S, DaSilva J . The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am J Psychiatry. 2001; 158(1):78-85. DOI: 10.1176/appi.ajp.158.1.78. View

Ichise M, Liow J, Lu J, Takano A, Model K, Toyama H . Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003; 23(9):1096-112. DOI: 10.1097/01.WCB.0000085441.37552.CA. View

Adams K, Pinborg L, Svarer C, Hasselbalch S, Holm S, Haugbol S . A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage. 2004; 21(3):1105-13. DOI: 10.1016/j.neuroimage.2003.10.046. View

Olsen L, Mortensen E, Bech P . Mental distress in the Danish general population. Acta Psychiatr Scand. 2006; 113(6):477-84. DOI: 10.1111/j.1600-0447.2005.00743.x. View

Cahir M, Ardis T, Reynolds G, Cooper S . Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology (Berl). 2006; 190(4):497-506. DOI: 10.1007/s00213-006-0635-5. View

le Roux C, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A . Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007; 246(5):780-5. DOI: 10.1097/SLA.0b013e3180caa3e3. View

Gunther L, Liebscher S, Jahkel M, Oehler J . Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice. Eur J Pharmacol. 2008; 593(1-3):49-61. DOI: 10.1016/j.ejphar.2008.07.011. View

Asarian L . Loss of cholecystokinin and glucagon-like peptide-1-induced satiation in mice lacking serotonin 2C receptors. Am J Physiol Regul Integr Comp Physiol. 2008; 296(1):R51-6. DOI: 10.1152/ajpregu.90655.2008. View

Sjostrom L . Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond). 2009; 32 Suppl 7:S93-7. DOI: 10.1038/ijo.2008.244. View

10.

Erritzoe D, Frokjaer V, Haugbol S, Marner L, Svarer C, Holst K . Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage. 2009; 46(1):23-30. DOI: 10.1016/j.neuroimage.2009.01.050. View

11.

Licht C, Marcussen A, Wegener G, Overstreet D, Aznar S, Knudsen G . The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J Neurochem. 2009; 109(5):1363-74. DOI: 10.1111/j.1471-4159.2009.06050.x. View

12.

Pi-Sunyer X . The medical risks of obesity. Postgrad Med. 2009; 121(6):21-33. PMC: 2879283. DOI: 10.3810/pgm.2009.11.2074. View

13.

Erritzoe D, Holst K, Frokjaer V, Licht C, Kalbitzer J, Nielsen F . A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans. J Neurosci. 2010; 30(9):3391-7. PMC: 6634111. DOI: 10.1523/JNEUROSCI.2852-09.2010. View

14.

Erritzoe D, Frokjaer V, Haahr M, Kalbitzer J, Svarer C, Holst K . Cerebral serotonin transporter binding is inversely related to body mass index. Neuroimage. 2010; 52(1):284-9. DOI: 10.1016/j.neuroimage.2010.03.086. View

15.

Takahashi T . Toward molecular neuroeconomics of obesity. Med Hypotheses. 2010; 75(4):393-6. DOI: 10.1016/j.mehy.2010.04.006. View

16.

Lam D, Garfield A, Marston O, Shaw J, Heisler L . Brain serotonin system in the coordination of food intake and body weight. Pharmacol Biochem Behav. 2010; 97(1):84-91. DOI: 10.1016/j.pbb.2010.09.003. View

17.

Di Iorio C, Watkins T, Dietrich M, Cao A, Blackford J, Rogers B . Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users. Arch Gen Psychiatry. 2011; 69(4):399-409. PMC: 3538835. DOI: 10.1001/archgenpsychiatry.2011.156. View

18.

Urban N, Girgis R, Talbot P, Kegeles L, Xu X, Frankle W . Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907. Neuropsychopharmacology. 2012; 37(6):1465-73. PMC: 3327851. DOI: 10.1038/npp.2011.332. View

19.

Ratner C, Ettrup A, Bueter M, Haahr M, Compan V, le Roux C . Cerebral markers of the serotonergic system in rat models of obesity and after Roux-en-Y gastric bypass. Obesity (Silver Spring). 2012; 20(10):2133-41. PMC: 3562999. DOI: 10.1038/oby.2012.75. View

20.

Berthoud H, Zheng H, Shin A . Food reward in the obese and after weight loss induced by calorie restriction and bariatric surgery. Ann N Y Acad Sci. 2012; 1264:36-48. PMC: 3464359. DOI: 10.1111/j.1749-6632.2012.06573.x. View